News
Endologix Announces First Patient Treated in Ventana(TM) U.S. Clinical Trial
Posted on : 01 June 2014
MHRA issues statement on metal-on-metal hip implants
Posted on : 30 January 2012
The MHRA have issued a statement on DePuy's metal-on-metal hip implants, while the Telegraph newspaper reports concerns that the devices could be more dangerous than previously thought... Read more
Medtronic completes enrollment of extreme risk patient group in CoreValve trial
Posted on : 25 January 2012
Medtronic has announced the completion of the company's patient enrollment in the extreme risk study in its CoreValve U.S. Trial... Read more
Which Medical Device launches new anaesthetics device section
Posted on : 23 January 2012
Which Medical Device is delighted to launch a new section dedicated to anaesthetics devices... Read more
DePuy suspends distribution of custom devices following FDA warning
Posted on : 23 January 2012
Johnson & Johnson subsidiary Depuy Orthopaedics has decided to stop selling all custom devices following an FDA letter warning... Read more
Rise in knee replacements among 30 to 59 year-olds
Posted on : 20 January 2012
A study reports a rise in the incidence of knee arthroplasty for primary osteoarthritis among baby-boomers in Finland... Read more
Gore receives FDA approval for TAG Thoracic Endoprosthesis
Posted on : 19 January 2012
The FDA has approved the GORE TAG Thoracic Endoprosthesis for endovascular repair of the descending thoracic aorta... Read more
Device of the Year 2011 Winners Announced!
Posted on : 16 January 2012
Which Medical Device are delighted to announce the winners of the Device of the Year Awards 2011... Read more
JACC study suggests increase in CeV events after TAVI
Posted on : 10 January 2012
A JACC study has found an increase in CeV events for two months after TAVI... Read more
Research shows lower adverse-events for drug-eluting stents than bare metal stents in patients over 85
Posted on : 04 January 2012
A report published in the Journal of the American College of Cardiology has observed lower adverse-event rates associated with DES versus BMS use. Read more
Study suggests RFA could be first-line treatment for early-stage HCC patients
Posted on : 03 January 2012
A study published in The American Journal of Gastroenterology suggests RFA might be a first-line treatment for selected patients with early-stage Hepatocellular Carcinoma. Read more
